Atara Biotherapeutics Inc. Company Profile
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.97-0.40 (-4.27%)
Market open · Delayed 15 min · as of Oct 8, 3:39 PM ET
Atara Biotherapeutics at a glance
Atara Biotherapeutics Inc. (NASDAQ: ATRA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2014. At a market capitalization of $94.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001604464, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Atara Biotherapeutics Inc.
- Ticker
- NASDAQ: ATRA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2014
- Market cap
- $94.05M
- SEC CIK
- 0001604464
Companies similar to Atara Biotherapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NMRANeumora Therapeutics Inc. | 0.4714 | +0.66% | $88.57M | vs ATRA |
| BDTXBlack Diamond Therapeutics Inc. | 1.78 | -2.73% | $102.00M | vs ATRA |
| CGTXCognition Therapeutics Inc. | 0.8946 | -4.48% | $85.07M | vs ATRA |
| CRDFCardiff Oncology Inc. | 1.05 | -3.67% | $81.69M | vs ATRA |
| PTHSPelthos Therapeutics Inc. | 20.97 | -0.10% | $80.28M | vs ATRA |
| GRMLGreenland Mines Ltd. | 5.78 | -0.86% | $77.15M | vs ATRA |
| LENZLENZ Therapeutics Inc. | 3.56 | -1.66% | $111.86M | vs ATRA |
| OKYOOKYO Pharma Limited | 1.37 | -4.47% | $71.63M | vs ATRA |